BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes through targeted T-cell activation.
In a newly published review, Professor Xiao-Jun Huang's team at Peking University People's Hospital explore how haploidentical hematopoietic stem cell transplantation (haplo-HSCT), once limited by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback